药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cryptenamine
Phosmet
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Phosmet.
Cryptenamine
Famphur
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Famphur.
Cryptenamine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Chlorcyclizine.
Cryptenamine
Eribulin
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Eribulin.
Cryptenamine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Geranylgeranyl diphosphate.
Cryptenamine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Farnesyl diphosphate.
Cryptenamine
Triptorelin
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Triptorelin.
Cryptenamine
Histrelin
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Histrelin.
Cryptenamine
Buserelin
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Buserelin.
Cryptenamine
Degarelix
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Degarelix.
Cryptenamine
Pasireotide
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Pasireotide.
Cryptenamine
Cariporide
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Cariporide.
Cryptenamine
Tandutinib
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Tandutinib.
Cryptenamine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Farnesyl thiopyrophosphate.
Cryptenamine
Vorinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Vorinostat.
Cryptenamine
Pheniramine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Pheniramine.
Cryptenamine
Ajmaline
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Ajmaline.
Cryptenamine
Bretylium
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Bretylium.
Cryptenamine
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Desipramine.
Cryptenamine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Desipramine.